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Abstract. Aim: The aim of this study was to investigate the
antitumor potential of guaiazulene-3-carboxylate derivatives
against oral malignant cells. Materials and Methods: Twelve
guaiazulene-3-carboxylate derivatives were synthesized by
introduction of either with alkyl group [1-5], alkoxy group [6,
7], hydroxyl group [8, 9] or primary amine [10-12] at the end
of sidechains. Tumor-specificity (TS) was calculated by the
ratio of mean 50% cytotoxic concentration (CC50) against 3
human oral mesenchymal cell lines to that against 4 human
oral squamous cell carcinoma (OSCC) cell lines. Potency-
selectivity expression (PSE) was calculated by dividing TS
value by CC50value against OSCC cell lines. Cell cycle
analysis was performed by cell sorter. Results: [6, 7] showed
the highest TS and PSE values, and induced the accumulation
of both subG1 and G2/M cell populations in HSC-2 OSCC
cells. Quantitative structure-activity relationship analysis
demonstrated that their tumor-specificity was correlated with
chemical descriptors that explain the 3D shape, electric state
and ionization potential. Conclusion: Alkoxyl guaiazulene-3-
carboxylates [6, 7] can be potential candidates of lead
compound for developing novel anticancer drugs.
Azulene (Figure 1A) is an isomer of naphthalene having a
dipole moment and a resonance energy with intermediate values
between that of benzene and naphthalene; it is considerably
more reactive, when compared with these two arenes (1-4).
Among the 962 papers cited in PubMed regarding azulenes,
most of them have focused on its chemistry, followed by
biological activity, while few papers have focused on dentistry
and oral application. Sodium azulene sulfonates have been
reported to be effective for the treatment of oral mucositis (5)
and oral lichen planus (6), possibly due to their antioxidant and
anti-inflammatory activities (7, 8). In contrast, much reduced
numbers of papers of guaiazulene (Figure 1B), a lipophilic
azulene derivative, have been published, approximately half of
which have dealt with its chemistry. Guaiazulenes also have
antioxidant and anti-inflammatory activities (9-11) and a few
papers have dealt with the treatment of oral diseases (12, 13).
As far as we know, anticancer potential of guaiazulene
derivatives against human oral malignant cells has not yet
been reported. This urged us to initiate the investigation of
10 alkylaminoguaiazulenes (Figure 1C) (14), 10 guaiazulene
amides (Figure 1D) (15) and 14 azulene amide derivatives
without or with 7-isopropylgroup (Figure 1E, F) (16). We
have reported that the introduction of an isopropyl group in
the seven-member ring and an amide group rather than
alkylamino group in the five-member ring of guaiazulene
increased the specific cytotoxicity against malignant cells
over non-malignant cells (14-16) (Figure 1). Furthermore,
quantitative structure-activity relationship (QSAR) analyses
demonstrated the tight correlation of their tumor-specificity
with hydrophobicity and molecular shape (15, 16).
The aim of the present study was to search for more
tumor-selective guaiazulene derivatives. For this purpose, we
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synthesized a total of 12 guaiazulene-3-carboxylate
derivatives [1-12] (Figure 1), in which alkyl group [1-5],
alkoxy group [6, 7], hydroxyl group [8, 9] and primary
amine [10-12] were introduced at the end of sidechain
(Figure 1G), and investigated their tumor-specificity using
four human oral squamous cell carcinoma (OSCC) cell lines
and three human normal oral cells. We also investigated the
effects of these compounds on cell cycle phase distribution,
in OSCC cells.
Materials and Methods
Materials. The following chemicals were obtained from the
indicated companies: Dulbecco’s modified Eagle’s medium
(DMEM) from Gibco BRL, Grand Island, NY, USA); fetal bovine
serum (FBS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) from Sigma-Aldrich Inc., St. Louis, MO, USA; 5-
fluorouracil (5-FU) from Kyowa, Tokyo, Japan; cisplatin (CDDP)
from Nichi-Iko Pharmaceutical Co. Ltd., Toyama, Japan; carboplatin
(CBDCA) from Sawai Pharmaceutical Co. Ltd., Osaka, Japan;
Paclitaxel (PTX) from Nipro Corporation, Osaka, Japan; dimethyl
sulfoxide (DMSO) and actinomycin D (Act. D) from Wako Pure
Chem. Ind., Osaka, Japan. Regarding consumables, 100-mm treated
culture dishes were purchased from TrueLine, Nippon Genetics Co.,
Ltd, Tokyo, Japan and 96-well plates from Techno Plastic Products
AG, Trasadingen, Switzerland.
Synthesis of guaiazulene-3-carboxylate derivatives. Methyl
guaiazulene-3-carboxylate [1], ethyl guaiazulene-3-carboxylate [2],
n-propyl guaiazulene-3-carboxylate [3], isopropyl guaiazulene-3-
carboxylate [4], n-butyl guaiazulene-3-carboxylate [5], 2-
methoxyethyl guaiazulene-3-carboxylate [6], 2-ethoxyethyl
guaiazulene-3-carboxylate [7], 2-hydroxyethyl guaiazulene-3-
carboxylate [8], 2-(2-hydroxyethoxy)ethyl guaiazulene-3-carboxylate
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Figure 1. Structure of azulene (A), guaiazulene (B), alkylaminoguaiazulenes (C), guaiazulene amides (D), azulene amide derivatives without (E) or
with 7-isopropylamino group (F), and 12 guaiazulene-3-carboxylate derivatives used in this study (G).
[9], 2-aminoethyl guaiazulene-3-carboxylate [10], 3-aminoprpyl
guaiazulene-3-carboxylate [11], 4-aminobutyl guaiazulene-3-
carboxylate [12] (Figure 1G) were synthesized, according to previous
reports (6, 17, 18). N-(2-methoxyethyl)guaiazulenecarboxamide [X]
was synthesized as previously described (15). All compounds were
dissolved in DMSO at 40 mM and stored at –20˚C before use.
Cell culture. Human normal oral cells [gingival fibroblast (HGF),
periodontal ligament fibroblast (HPLF), pulp cell (HPC)] (19) at
12~20 population doubling level (PDL) and OSCC cell lines (Ca9-
22, HSC-2, HSC-3, HSC-4) (Riken Cell Bank, Tsukuba, Japan)
were cultured at 37˚C in DMEM supplemented with 10% heat-
inactivated FBS and antibiotics under humidified 5% CO2
atmosphere, as described previously (14-16). 
Assay for cytotoxic activity. Cells were inoculated at 2×103 cells/0.1
ml in a 96-microwell plate. After 48 h, the medium was replaced
with 0.1 ml of fresh medium containing various concentrations of
test compounds. Control cells were treated with the same amounts
of DMSO present in each diluent solution. Cells were incubated for
48 h and the relative viable cell number was then determined by the
MTT method, as described previously (14-16). The CC50 was
determined from the dose–response curve of triplicate samples.
Calculation of tumor-selectivity index (TS). TS(mean) was
calculated as the ratio of the mean CC50 value for the human normal
oral cells (HGF+HPLF+HPC) to that for the OSCC cell lines (Ca9-
22+HSC-2+HSC-3+HSC-4). Moreover, TS was calculated for cells
derived from gingival tissue (20), and as the ratio of CC50 (HGF)
to CC50 (Ca9-22) (TS(HGF/Ca9-22)).
Calculation of potency-selectivity expression (PSE). PSE was
calculated by the formula: (TS/CC50) ×100 (11, 12).
Cell cycle analysis. Cells (approximately 106 cells) were harvested,
fixed, treated with ribonuclease A, stained propidium iodide, filtered
through cell strainers and then were subjected to cell sorting (SH800
Series, SONY Imaging Products and Solutions Inc., Atsugi,
Kanagawa, Japan) and cell cycle analysis (Cell Sorter Software
version 2.1.2., SONY Imaging Products and Solutions Inc), as
described previously (16).
Calculation of chemical descriptors. pCC50 (i.e., the −log CC50)
was used for the comparison of the cytotoxicity between the
compounds, since the CC50 values had a distribution pattern close
to a logarithmic normal distribution. The mean pCC50 values for
normal cells and tumor cell lines were defined as N and T,
respectively (15, 16) (Table II). The 3D-structure of each chemical
structure was drawn by Marvin Sketch (MarvinSketch 18.10.0,
ChemAxon, Budapest, Hungary, http://www.chemaxon.com), and
optimized by CORINA Classic (Molecular Networks GmbH,
Nürnberg, Germany) with forcefield calculations (amber-10: EHT)
in Molecular Operating Environment (MOE) version 2019.0101
(Chemical Computing Group Inc., Quebec, Canada) and Dragon
(Dragon 7 version 7.0.2, Kode srl., Pisa, Italy). 
Statistical analysis. Each experimental value was expressed as the
mean±standard deviation (SD) of triplicate or quadruplicate
measurements. The statistical analysis was performed using one-
way analysis of variance (ANOVA) followed by Bonferroni’s post-
hoc test for multiple comparisons. The correlation between chemical
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Table I. Cytotoxicity and tumor-specificity (evaluated by TS and PSE values) of 12 guaiazulene-3-carboxylate derivatives against human oral
squamous cell carcinoma (OSCC) cell lines and human normal oral cells (normal).
Compound                       CC50**                                    TS                                             PSE                                       T***            N***              T-N***
                            OSCC               Normal          TSmean      TS(HGF/Ca9-22)        PSEmean       PSE(HGF/Ca9-22)                                      
                                 
1*                     154.5±29.8        192.9±33.9       1.3±0.1            1.2±0.4               0.8±0.2               0.9±0.3                0.81093        0.71479         0.09613 
2                        137.7±8.6         217.6±41.3       1.6±0.3            1.5±0.6               1.1±0.2               1.2±0.5                0.86125        0.66258         0.19867 
3*                      54.2±26.0         102.4±35.2       2.0±0.4            2.0±1.0               4.9±3.9               6.1±6.5                1.26527        0.98981         0.27546 
4*                       45.0±7.1           82.0±14.4        1.8±0.1            1.7±0.8               4.1±0.6               3.9±1.9                1.34630        1.08584         0.26046 
5*                       78.7±5.2          225.9±12.3       2.9±0.3            2.2±1.3               3.7±0.6               2.9±1.9                1.10286        0.64636         0.45650 
6*                       34.8±5.6          155.6±29.3       4.5±0.2            4.4±3.3              13.0±1.9            13.8±10.1              1.45959        0.80807         0.65151
7                         28.0±2.1          125.2±55.3       4.4±1.7            3.7±3.5              15.5±5.2            16.1±15.5              1.55350        0.90238         0.65112
8*                       50.5±3.9           97.9±16.8        2.0±0.4            2.1±1.4               3.9±1.0               4.7±3.4                1.29614        1.00898         0.28716 
9*                      43.3±16.0          92.9±34.3        2.1±0.0            2.8±1.5               5.6±2.6              10.3±4.7               1.36349        1.03337         0.33013 
10*                     26.9±1.4           65.0±11.4        2.4±0.4            3.6±2.5               9.0±1.5             18.1±13.5              1.57208        1.18668         0.38540 
11*                     17.7±5.2            31.8±4.9         1.9±0.4            1.7±0.4              11.6±6.0              9.3±4.7                1.75417        1.49840         0.25576 
12*                     19.7±1.4            34.1±1.3         1.7±0.1            1.8±0.3               8.8±0.9               9.7±3.0                1.70885        1.46693         0.24192 
5-FU                  63.8±3.8         578.7±328.7      8.8±4.6          51.6±13.0            13.4±6.5          895.6±776.5            1.19510        0.23770         0.95741 
CDDP                 2.6±1.2              4.0±1.2          2.2±1.5            1.4±0.6           136.3±117.3         56.5±28.7              2.56540        2.39794         0.16746 
CBDCA             3.6±0.8              8.1±3.1         2.4± 1.1           1.6±0.6             69.3±38.1           34.5±14.5              2.44186        2.09691         0.34495 
5-FU: Fluorouracil; CDDP: cisplatin; CBDCA, carboplatin; TS: tumor-selectivity index; PSE: potency-selectivity expression; TSmean: CC50
(normal)/CC50 (OSCC); TS(HGF/ Ca9-22): CC50 (HGF)/CC50 (Ca9-22); PSEmean: [TS(mean)/CC50 (OSCC)]×100; PSE(HGF/Ca9-22): [TS(HGF/Ca9-22)/CC50
(Ca9-22)]×100. Bold values represent the highest values of TS, PSE and T-N among 12 compounds. *Significant difference (p<0.05) between the mean
of CC50 of OSCC cells and that of normal cells. **Presented as mean±SD. ***The negative log CC50 (pCC50) values for tumor and normal cells,
respectively. The difference (T–N) was used as a tumor-selectivity index. Each value represents the mean±SD from three independent experiments that
were done in triplicate.
descriptors and cytotoxicity or tumor specificity index was
investigated using linear regression analyses. The significance level
was set at p<0.05. Statistical analysis was performed using the JMP
Pro version 14.3.0 software (SAS Institute Inc., Cary, NC, USA).
Results
Cytotoxicity and tumor-specificity. Twelve guaiazulene-3-
carboxylate derivatives used in this study were classified into
four groups: alkyl guaiazulene-3-carboxylates [1-5], alkoxyl
guaiazulene-3-carboxylates [6, 7], hydroxyalkyl guaiazulene-
3-carboxylates [8, 9] and aminoalkyl guaiazulene-3-
carboxylates [10-12] (Figure 1G). We compared their
cytotoxic activity against four human oral squamous cell
carcinoma (OSCC) cell lines (Ca9-22, HSC-2, HSC-3, HSC-
4) and three normal oral cells (HGF, HPLF, HPC), by
comparing the 50% cytotoxic concentration (CC50)
determined from the dose-response curve (Table I). We have
adopted 48 h treatment time, based on our observation that
significant (p<0.05) cytotoxicity of compounds [6, 7]
appeared 3 h after treatment, reaching the plateau level after
24~48 h (Figure 2). We have repeated the same experiments
3 times. The mean values of CC50, tumor-selectivity index
(TS), and potency-selectivity expression (PSE) of these
twelve compounds, as well as of positive controls (5-FU,
CDDP, and CBDCA) obtained from these 3 independent
experiments are listed in Table I. Most of the compounds [1,
3, 4-6, 8-12] showed significantly higher cytotoxicity against
OSCC cell lines, compared to normal cells (p<0.05). Among
the 12 studied guaiazulene-3-carboxylates, two alkoxyl
guaiazulene-3-carboxylates [6, 7] (TSmean=4.4±0.2;
PSE=13.0±1.9) showed the highest TS values than five alkyl
guaiazulene-3-carboxylates [1-5], two hydroxyalkyl
guaiazulene-3-carboxylates [8, 9], and three aminoalkyl
guaiazulene-3-carboxylates [10-12] (Table I). Moreover, both
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Table II. Top six chemical descriptors that correlate with cytotoxicity to tumor cells, normal cells and tumor-specificity (having the highest r2
values).
               Descriptor         Source                   Meaning                                 Category                                                     Explanation
T               BCUT_             MOE            Topological shape             Adjacency and distance                    The BCUT descriptors using atomic 
               SLOGP_0                                                                               matrix descriptors                   contribution to logP (using the Wildman and
                                                                                                                                                            Crippen SlogP method) instead of partial charge.
                     Mi               Dragon          Ionization potential              Constitutional indices      Mean first ionization potential (scaled on Carbon atom)
                 Mor24e           Dragon   3D shape and electric state      3D-MoRSE descriptors         Signal 11/weighted by Sanderson electronegativity
                     C%              Dragon       Percentage of C atoms           Constitutional indices                                  Percentage of C atoms
                 Mor24i           Dragon              3D shape and                3D-MoRSE descriptors                Signal 10/weighted by ionization potential
                                                               ionization potential
                   DISPi             Dragon          3D shape, size and            Geometrical descriptors       Displacement value/weighted by ionization potential
                                                               ionization potential
N            vsurf_Wp2          MOE                3D shape and              Surface area, Volume and                                     Polar volume
                                                                    polarizability                      Shape descriptors                                                        
               vsurf_IW1          MOE                3D shape and                  Surface area, Volume                             Hydrophilic integy moment
                                                                   hydrophilicity                  and Shape descriptors
                 h_logD             MOE                 Lipophilicity                     Physical properties             The octanol/water distribution coefficient at pH 7.
              vsurf_Wp3          MOE                3D shape and                  Surface area, Volume                                         Polar volume
                                                                    polarizability                   and Shape descriptors
                RDF010s          Dragon          3D shape, size and                  RDF descriptors                                Radial Distribution Function - 
                                                                    electric state                                                                                        010/weighted by I-state
                 BCUT_             MOE            Topological shape             Adjacency and distance         The BCUT descriptors using atomic contribution
               SLOGP_0                                                                               matrix descriptors                      to logP (using the Wildman and Crippen 
                                                                                                                                                                   SlogP method) instead of partial charge.
T-N             MEcc             Dragon                  3D shape                   Geometrical descriptors                                Molecular eccentricity
                     L3s              Dragon          3D shape, size and                WHIM descriptors                       2nd component size directional WHIM 
                                                                    electric state                                                                                      index/weighted by I-state
            SpMAD_G/D      Dragon           3D shape and size                   3D matrix-based                            Spectral mean absolute deviation 
                                                                                                                     descriptors                                     from distance/distance matrix
                    L3m              Dragon          3D shape, size and                WHIM descriptors                       3rd component size directional WHIM 
                                                                    electric state                                                                                       index/weighted by mass
                     H2i              Dragon              3D shape and                          GETAWAY                               H autocorrelation of lag 8/weighted 
                                                               ionization potential                       descriptors                                           by ionization potential
                 TDB10i           Dragon              3D shape and                                 3D                               3D topological distance-based descriptors -
                                                               ionization potential                  autocorrelations                         lag 10 weighted by ionization potential
[6, 7] showed higher TS value than CDDP and CBDCA
(TSmean=2.2±1.5 and 2.4±1.1, respectively), and had
PSE(mean) values comparable to that of 5-FU (13.4±6.5).
Regarding TS(HGF/Ca9-22) and PSE(HGF/Ca9-22), high SD
values were observed, possibly due to a cytostatic, rather
than cytotoxic inhibition of cell proliferation, causing
variations of CC50 values in each experiment (Table I). 
Induction of apoptosis and G2/M arrest. Light microscopical
observation (Figure 3A) revealed that HSC-2 cells treated for
48 h with 20 μM of either [6] or [7] (slightly lower
concentration of their CC50: 34.8 and 28.0 μM, Table I) were
a mixture of shrunken and spread cells. Cell cycle analysis
demonstrated that when compared to the control, [6, 7]
significantly (p<0.05) reduced the G1 cell population, while
increased the subG1 and G2/M phase cells, regardless of
treatment time (24 h and 48 h) (Figure 3B, 3C). Actinomycin
D (Act. D) increased more the percentage of subG1 cell
population (p<0.05), but slightly reduced (p<0.05) the G2/M
phase cells at 24 h (Figure 3B, 3C). 
Computational analysis. The number of descriptors calculated
from MOE and dragon were 344 and 5,255, respectively. As
a result of excluding duplicates or descriptors with standard
deviation of 0, the number of descriptors reduced to 264,
2,808, respectively. Among a total of 3,072 descriptors, the top
six descriptors that showed the highest correlation coefficient
(r2) to T, N and T-N are listed in Table II. 
Cytotoxicity against human OSCC cell lines was correlated
with descriptors BCUT_SLOGP_0 (r2=0.841, p<0.0001)
(topological shape), Mi (r2=0.785, p=0.0001) (ionization
potential), Mor24e (r2=0.757, p=0.0002) (3D shape and
electric state), C% (r2=0.751, p=0.0003) (percentage of C
atoms), Mor24i (r2=0.737, p=0.0003) (3D shape and
ionization potential) and DISPi (r2=0.734, p=0.0004) (3D
shape, size and ionization potential) (Figure 4). 
Cytotoxicity against human normal oral mesenchymal cells
was correlated with descriptors vsurf_Wp2 (r2=0.783,
p=0.0001) (3D shape and polarizability), vsurf_IW1 (r2=0.753,
p=0.0003) (3D shape and hydrophilicity), h_logD (r2=0.751,
p=0.0003) (lipophilicity), vsurf_Wp3 (r2=0.740, p=0.0003) (3D
shape and polarizability), RDF010s (r2=0.730, p=0.0004) (3D
shape, size and electric state), and BCUT_SLOGP_0
(r2=0.678, p=0.0010) (topological shape) (Figure 5).
Tumor-specificity was correlated with descriptors MEcc
(r2=0.696, p=0.0007) (3D shape), L3s (r2=0.692, p=0.0008)
(3D shape, size and electric state), SpMAD_G/D (r2=0.678,
p=0.0010) (3D shape and size), L3m (r2=0.649, p=0.0016)
(3D shape, size and electric state), H2i (r2=0.648, p=0.0016)
(3D shape and ionization potential) and TDB10i (r2=0.646,
p=0.0016) (3D shape and ionization potential) (Figure 6).
These data suggest that both tumor-specificity and
cytotoxicity of guaiazulene-3-carboxylate against OSCC
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Figure 2. Time- and dose-response of cytotoxicity induction by [6] and [7].
HSC-2 cells were incubated for 1, 3, 6, 24 or 48 h with the indicated
concentrations of [6] or [7], and then the viable cell number was
determined by MTT method. Each value represents mean±SD of triplicate
assays. The differences between control and treated groups were evaluated
by one-way analysis of variance (ANOVA) followed by Bonferroni’s post-
hoc test for multiple comparisons. *p<0.05 compared with control.
correlate with 3D shape, electric state, and especially
ionization potential.
Discussion
The present study demonstrated that among twelve
guaiazulene-3-carboxylates, two alkoxyl guaiazulene-3-
carboxylates [6, 7] showed higher tumor-specificity than five
alkyl [1-5] and two hydroxyalkyl [8, 9] guaiazulene-3-
carboxylates and three aminoalkyl guaiazulene-3-carboxylate
carboxamides [10-12] (Table I). Both [6, 7] showed higher
TS value than CDDP and CBDCA, and having comparable
PSE value with 5-FU (Table I). Higher TS of [6, 7] might be
explained by their 3D shape, electric state and especially
ionization potential (Figure 6). This point was confirmed by
the fact that when carboxylate portion in [6] was replaced
with amide (N-(2-methoxyethyl)guaiazulenecarboxamide
[X]), both TS and PSE were reduced (Figure 7). Guaiazulene
has been reported to induce apoptosis in normal HGF (21).
Therefore, compounds with much higher tumor-specificity
should be synthesized.
PubMed search demonstrated that no paper published on
the G2/M arrest by guaiazulene. Therefore, the present
study demonstrated for the first time that [6, 7] induced
cell shrinkage and subG1 cell accumulation (one of the
markers of apoptosis) (22, 23), as well as G2/M cell
accumulation (indication of mitotic arrest). We have
recently reported that 7-isopropyl-3-methyl-N-
propylazulene-1-carboxamide and 2-methoxy-N-
pentylazulene-1-carboxamide, both of which do not have
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Figure 3. Production of subG1 and G2/M cell populations by [6, 7]. HSC-2 cells were treated for 48 h or 24 h without (control) or with 20 μM [6],
20 μM [7] or 1 μM actinomycin D (Act. D) and then cell morphology (A) and cell cycle distribution (assessed by cell sorter) (B) were investigated.
(C) Summary of the data of cell cycle distribution after 24 and 48 h. Each value represents mean±SD of triplicate assays. *p<0.05: Statistical
significance from control. Scale of bar in (A): 100 μm.
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Figure 4. Determination of coefficient between chemical descriptors and cytotoxicity of 12 guaiazulene-3-carboxylate derivatives against tumor
cells (defined as T). The mean (pCC50 i.e., the −log CC50) values for tumor cell lines were defined as T.
Figure 5. Determination of coefficient between chemical descriptors and cytotoxicity of 12 guaiazulene-3-carboxylate derivatives against normal
cells (defined as N). The mean (pCC50 i.e., the −log CC50) values for normal cells were defined as N.
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Figure 6. Determination of coefficient between chemical descriptors and tumor specificity of 12 guaiazulene-3-carboxylate derivatives (defined as T−N).
Figure 7. Comparison of tumor-specificity (TS) values between [6] and N-(2-methoxyethyl)guaiazulenecarboxamide [X]. Four OSCC cell lines and
three normal cells were incubated for 48 h with the indicated concentrations of [6] or [X] that was synthesized as previously described (15), and
then TS and potency-selectivity expression (PSE) values were determined. Each value represents mean of triplicate assays. 
guaiazulene structure, did not induce the accumulation at
G2/M, although they induced apoptosis in HSC-2 cells
(16). Taken together, the presence of guaiazulene structure
may be involved in G2/M arrest induction; however,
further study is required to confirm the induction of
apoptosis markers by [6, 7] and investigate the possible
link of G2/M arrest and apoptosis induction. 
We have recently reported that several G2/M blockers such
as taxanes paclitaxel [Taxol®, the first microtubule stabilizing
agent (24)] and docetaxel (25), and 3-styrylchromone
derivatives [7-methoxy-3-[(1E)-2-phenylethenyl]-4H-1-
benzopyran-4-one, 3-[(1E)-2-(4-hydroxyphenyl)ethenyl]-7-
methoxy-4H-1-benzopyran-4-one] show very high TS values
(>7267, >86122, 301 and 182, respectively) (26). However,
many reports, including ours, demonstrated that microtubule-
targeted agents have potent neurotoxicity, adversely affecting
the quality of life of patients on a long-term basis (27-30). We
have also reported that doxorubicin induced very potent
keratinocyte toxicity by inducing apoptosis, characterized by
the loss of cell surface microvilli, chromatin condensation,
nuclear fragmentation and caspase-3 activation (31).
Therefore, the possible side effects of guaiazulene-3-
carboxylate derivatives such as neurotoxicity and keratinocyte
toxicity should be evaluated. 
In conclusion, the present study demonstrated for the first
time that two guaiazulene-3-carboxylate derivatives with
alkoxy group at the end of sidechain [6, 7] showed highest
TS against OSCC cell lines, among 12 related compounds,
and induced subG1 and G2/M arrest. TS was correlated with
chemical descriptors that explain the 3D shape, electric state,
and ionization potential. These two compounds can be
potential candidates of lead compound for manufacturing
new type of anticancer drugs. Further study is ongoing by
our team, regarding combination of [6] or [7] and anticancer
drugs against the human OSCC HSC-2 cell line.
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